gemcitabine + S-1

DRUG2 trials

Sponsors

Japan Clinical Cancer Research Organization, AstraZeneca

Conditions

Biliary Tract CancerPancreatic Cancer

Phase 2

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

CompletedNCT00514163

Japan Clinical Cancer Research OrganizationPancreatic Cancer

Start: 2007-06-30End: 2010-12-31Target: 110Updated: 2011-06-28

Phase 3

Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

Active, not recruitingNCT05771480

AstraZenecaBiliary Tract Cancer

Start: 2023-08-16End: 2026-09-17Updated: 2026-03-25

Related Papers

TOURMALINE: A phase 3b study of durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer.

Journal of Clinical Oncology2024-06-011 citations